Corporate News
Marwynn (MWYN)
- The share price ended the 24‑hour period at 02:14 PM Central Europe on Friday 23 th with a decline of 16.67 %.
- Current trading price is approximately USD 2.23 on major exchanges.
- Outstanding shares: 20.2 million.
- Market capitalization: USD 45.4 million.
- 24‑hour trading volume: USD 1.6 million.
- Year‑to‑date performance: up 114.29 % since the end of last month.
- 200‑day simple moving average: USD 0.94.
- 52‑week high: USD 2.70 on 20 October 2026.
- 52‑week low: USD 0.45 on 23 April 2026.
Related Stock Performance (last 24 hours)
| Ticker | Price | % Change | Market Capitalization | Notes |
|---|---|---|---|---|
| Eloxx (ELOX) | USD 13.12 | +0.61 % | USD 53.7 million | Board expansion to six directors; appointment of Geno J. Germano (independent director) and T.R. Srinivas, M.D. (Senior Vice President & Chief Medical Officer). Launch of EXPRESS Phase 2 clinical trial of exaluren for autosomal dominant polycystic kidney disease; first patient dosing expected late 2027; topline data slated 2029. Prospectus supplement filed for resale of 600,000 shares and up to 4.3 million shares issuable upon exercise of pre‑funded warrants. |
| Travelzoo (TZOO) | USD 5.09 | –2.86 % | USD 53.5 million | Price‑to‑earnings ratio: 159.13. New promotional packages announced for UK members: week‑long stay at a five‑star resort in Malta, two‑night accommodation at a historic house in the New Forest, and tickets to a West End musical with dinner. Packages include flights, transfers, meals, and local experiences. Promotion released by the London office. |
| Clene (CLNN) | USD 3.88 | +0.80 % | USD 53.4 million | – |
| Techprecision (TPCS) | USD 5.22 | –2.79 % | USD 54.2 million | – |
| Ibio (IBIO) | USD 0.78 | –7.14 % | USD 54 million | – |
All figures are current as of the specified 24‑hour period and are provided for informational purposes only.
